Company Profile
Hangzhou Alltest Biotech researches, develops, produces, and sells in vitro diagnostic reagents in China and globally. The company offers COVID-19 solutions, such as antigen combo rapid and antigen test range.
Its portfolio also includes HUMAN RAPID TESTs, including women's health, infectious disease, drugs of abuse, tumor markers, cardiac markers, home use, and rapid tests, LF readers, and veterinary products comprising veterinary chemiluminescence and fluorescence immunoassay, veterinary LF readers, dry biochemistry, and immunoblotting
Canine, feline, porcine, and bovine test ranges, as well as fluorescence immunoassay tests and analyzers. Its portfolio also includes urine analysis solutions, biochemistry reagents, blood glucose monitoring systems, Hb hemoglobin test meters, cholesterol meters, and VTM products, PCR kits, immunoblotting test kits, chemiluminescence immunoassay analyzers and tests, and blood grouping reagents. Founded in 2009, Hangzhou Alltest Biotech is headquartered in Hangzhou, China.